Comparison between mono-tacrolimus and mono-glucocorticoid in the treatment of myasthenia gravis.
Zhirong FanLin LeiShengyao SuShu ZhangNairong XieLing LiYan LuLi DiMin WangMin XuXin-Ming ShenYuwei DaPublished in: Annals of clinical and translational neurology (2023)
Mono-tacrolimus performs superior tolerability with non-inferior efficacy compared to mono-glucocorticoids in mild to moderate myasthenia gravis patients who refuse or have a contraindication to glucocorticoids.